Crossmark

Secukinumab as biological treatment for psoriatic arthritis in real clinical practice

Crossref DOI link: https://doi.org/10.1016/j.reumae.2020.02.002

Published Print: 2021-04

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pinto Tasende, José A.

Maceiras Pan, Francisco J.

Mosquera Martínez, José A.

Dominguez, Luis Fernández

Rey, Blanca Correa

Porrúa, Carlos García
License Information

Text and Data Mining valid from 2021-04-01
More Information

This article is maintained by: Elsevier

Article Title: Secukinumab as biological treatment for psoriatic arthritis in real clinical practice

Journal Title: Reumatología Clínica (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.reumae.2020.02.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.reuma.2019.07.002

Content Type: article

Copyright: © 2019 Elsevier España, S.L.U. and Sociedad Española de Reumatología y Colegio Mexicano de Reumatología. All rights reserved.